Tonya S Smith, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 300 S Washington St, Lexington, NE 68850 Phone: 308-324-1209 |
Samantha Kay Sleicher, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 300 S Washington St, Lexington, NE 68850 Phone: 308-324-1209 |
Jessica Lara, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 S Washington St, Lexington, NE 68850 Phone: 308-324-4681 |
Melanie Renae Steinwart, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 300 S Washington St, Lexington, NE 68850 Phone: 308-324-1209 Fax: 308-324-2528 |
Tracy Harbison, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 S Washington St, Lexington, NE 68850 Phone: 308-324-4681 |
Gloria Dawson, RN Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 1201 N Erie St, Lexington, NE 68850 Phone: 308-324-8315 |
News Archive
Sunesis Pharmaceuticals, Inc. presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8.
In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5 million people with HIV live more than 60 minutes from a healthcare facility, according to a new study published this week in the open-access journal PLOS Global Public Health by Diego Cuadros of the University of Cincinnati, and colleagues.
"Michelle Obama on Friday began the second leg of her weeklong visit to Africa by wielding a brush to help paint a mural" at the Botswana-Baylor Children's Clinical Center of Excellence in the capital city of Gaborone, the Associated Press reports. The clinic serves 4,000 children and their families who have been affected by HIV/AIDS, according to the news service (Superville, 6/24).
Today, Merck announced that Health Canada has approved GARDASIL(R) (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Recombinant Vaccine) for boys and men nine through 26 years of age for the prevention of infection caused by HPV types 6, 11, 16, and 18 and genital warts caused by HPV types 6 and 11.
A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years.
› Verified 8 days ago